Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Review of laquinimod and its therapeutic potential in multiple sclerosis.
B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System.
Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
Neural networks to identify multiple sclerosis with optical coherence tomography.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Data collection capabilities of a new non-invasive monitoring system for patients with advanced multiple sclerosis.
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
Sphingosine-1 phosphate and central nervous system.
Gait termination in individuals with multiple sclerosis.
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Exploring myelin dysfunction in multiple system atrophy.
Analysis of neuromuscular parameters in patients with multiple sclerosis and gait disorders.
Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis.
Perspectives of the relationship between IL-7 and autoimmune diseases.
Certified occupational therapy assistants.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
Pages
« first
‹ previous
…
489
490
491
492
493
494
495
496
497
…
next ›
last »